A seven-color panel including CD34 and TdT could be applied in >97% patients with T cell lymphoblastic leukemia for minimal residual disease detection independent of the initial phenotype
2010 ◽
Vol 78B
(3)
◽
pp. 139-146
◽
2017 ◽
Vol 50
(1)
◽
2018 ◽
Vol 40
(3)
◽
pp. 343-351
◽
2016 ◽
pp. 207-216